OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Clinical Pharmacology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
	67
Issue Information	66
Issue Highlights	63
Effect of oral clonidine on pain reduction in patients with opioid use disorder in the emergency department: A randomized clinical trial	56
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data	55
Selected Abstracts from Pharmacology 2024	55
Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pre	55
A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination	54
Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection	52
Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery	51
Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’	49
Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination	49
Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study	48
Intranasal vitamin B₁₂ administration in elderly patients: A randomized controlled comparison of two dosage regimens	41
Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects	39
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database	39
Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real‐world data and simulated data	39
Therapeutic drug monitoring of thiopurines: Effect of reduced 6‐thioguanine nucleotide target levels in inflammatory bowel disease patients	38
Triple antithrombotic therapy and dual therapy – What is the evidence base?	38
Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model	38
Antidepressants are not safe during pregnancy and in women of child‐bearing age	36
Postoperative ileus after digestive surgery: Network meta‐analysis of pharmacological intervention	36
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin	35
Comparison of a polypharmacy‐based scale with Charlson comorbidity index to predict 6‐month mortality in chronic complex patients after an ED visit	35
Lemborexant levels in breast milk after single doses in healthy, lactating women	34

Modelling the progression of illicit substance use patterns from real‐world evidence	34
Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?	32
Serum uric acid lowering mediated by glucagon‐like peptide‐1 receptor agonists: Emerging considerations	31
Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial	31
Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia	30
Pregabalin poisoning: Evaluation of dose‐toxicity relationship	30
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population	30